Seagen Inc

SGENStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$229.01

Today

+0.0%

YTD

+0.2%

About

Seattle Genetics Inc. was founded in 1998 and is headquartered in Bothell, Washington. The multi-product, global biotechnology company focuses on developing antibody-drug conjugate technology delivering cancer-killing therapy to tumor cells, meant for lymphoma patients. Seattle Genetics has collaborations with a line of biotechnology and pharmaceutical companies, including Bayer Pharma, Celldex Therapeutics, Genentech, Pfizer, and others, and maintains a co-development agreement with Agensys Inc. Interested in trading Seattle Genetics stocks? Follow this instrument for news and updates.

Price chart

Closing price history for SGEN (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-57.10

P/S (TTM)18.71

P/B (TTM)16.92

Market cap$39.20B

Cap tierLarge-cap

Industry avg P/E-7.40

Profitability

Gross margin74.65%

EBIT margin-34.37%

Net margin-33.27%

ROE-27.93%

ROA-20.69%

Earnings & Revenue

Revenue (TTM)$2.30B

Revenue growth (1Y)+23.4%

EPS (TTM)-$4.01

Free cash flow$-701.21M

Total debt$124.58M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.59

Employees3,256

Next earnings14 Feb '24

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.